Physician profile
Mark William Floyd
NPI 1811158249
$22,620.62
in general payments reported to CMS, 2019-2025
12 companies · $412 in 2025
The $412 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14K · 2020: $1,630 · 2021: $2,931 · 2022: $3,279 · 2023: $277 · 2024: $101 · 2025: $412.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $790.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $790.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $21,146.42 | 2019-2022 | |
| United Orthopedics LLC | $529.22 | 2022-2024 | |
| Depuy Synthes Sales INC. | $418.90 | 2019-2025 | Na, Va-Lcp, Tfn-Advance |
| Team 1, LLC | $169.93 | 2025 | |
| Shoulder Innovations, INC. | $117.48 | 2021 | |
| Smith+Nephew, INC. | $97.64 | 2019-2025 | Lens 4k, Q-Fix |
| Pacira Therapeutics, INC. | $47.62 | 2019 | |
| Ferring Pharmaceuticals INC. | $26.26 | 2019 | |
| Anika Therapeutics, INC. | $23.13 | 2023 | Wristmotion |
| Sanofi-Aventis U.S. LLC | $17.43 | 2022 | |
| Stryker Corporation | $13.55 | 2022 | |
| Orthofix Medical, INC. | $13.04 | 2025 | Physio-Stim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Floyd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.